.Pharmacolibrary.Drugs.V_Various.V10A_AntiinflammatoryAgents.V10AX05_Rhenium186reSulfideCollo.Rhenium186reSulfideCollo .Pharmacolibrary.Drugs.V_Various.V10A_AntiinflammatoryAgents.V10AX05_Rhenium186reSulfideCollo.Rhenium186reSulfideCollo| name: | Rhenium186reSulfideColloid | |
| ATC code: | V10AX05 | route: | intra-articular |
| compartments: | 1 | |
| dosage: | 40 | mg |
| volume of distribution: | 0.015 | L |
| clearance: | 0.0002 | liter/hour |
| other parameters in model implementation | ||
Rhenium (186Re) sulfide colloid is a radioactive therapeutic agent used primarily for radionuclide synovectomy to treat chronic inflammatory joint diseases such as rheumatoid arthritis. It is administered intra-articularly, delivering localized radiation to inflamed synovial tissue. It is used in some countries for radiosynovectomy procedures, but is not approved as a drug in all jurisdictions.
Estimated pharmacokinetic parameters for adult patients receiving intra-articular injection for synovectomy. No published population PK models or comprehensive pharmacokinetic data specific to this colloid could be found.